Brigham and Women's Hospital Names Neuropathologist as New Chairman

Dr. Jeffrey A. Golden

In an obvious attempt to keep up with Massachusetts General Hospital, whose pathology chief is neuropathologist Dr. David Louis, Brigham and Women's Hospital in Boston has just announced that another neuropathologist, Dr. Jeffrey Golden, will become chair of pathology at that institution. Effective March 1, 2012, Dr. Golden will become the Ramzi S. Cotran Professor of Pathology at Harvard Medical School.  Brigham President Betsy Nabel, MD had this to say in a statement released today: Dr. Golden comes to BWH "from The Children's Hospital of Philadelphia, where since 2008, he has been serving as Pathologist-in-Chief in CHOP's Department of Pathology and Laboratory Medicine, cited as one of the leading pathology and developmental biology programs in the U.S. and one of the top NIH-funded research programs in Pathology.... Dr. Golden is recognized as an outstanding clinician, a highly skilled educator focused on training the next generation of physician/scientists in pathology and developmental biology, and a cutting-edge basic and translational research leader.  His studies in the multiple aspects of developmental biology and early nervous system development are key to gaining a greater insight into the pathogenesis of human diseases, including brain malformations, mental retardation, epilepsy and autism.  His efforts to date of establishing and elevating the bench to bedside and back to bench paradigm in the fast changing field of developmental biology and molecular diagnostics reflects a true commitment to quality and excellence in the application of new knowledge at the front lines of patient care."

As one neuropathologist commented to another: "Apparently neuropath is now ruling the world."